UNSPSC 51342403: Nelfinavir mesilate or mesylate

This classification denotes a protease inhibitor with the molecular formula C32H45N3O4S.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98D603VP8V, chemically known as (3s,4as,8as)-n-tert-butyl-2-((2r,3r)-3-(3,2-cresotamido)-2-hydroxy-4-(phenylthio)butyl)decahydro-3-isoquinolinecarboxamide monomethanesulfonate (salt), but more generally known as nelfinavir mesylate, which bears US NIH Compound Identifier 64142.

UNSPSC 51342403 Nelfinavir mesilate or mesylate is a Commodity code that appears in state and local procurement activity with minimal direct relevance to its nominal pharmaceutical scope. The recent opportunities tagged to this code include naloxone and drug deactivation systems procurement (Seminole County, Florida IFB), a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs, medical and first aid supplies for fire rescue (City of Tampa IFB), and a Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products. The mismatch between the code name and actual solicitation content suggests either classification error in the source data or use of the code as a catch-all for pharmaceutical-related acquisitions by state and local health and procurement agencies. The actual work being solicited spans medical consumables (wound care, respiratory equipment, cardiac monitoring supplies), naloxone procurement for community health and overdose response, direct pharmaceutical distribution relationships, and cooperative purchasing of generic drugs and over-the-counter products through established wholesaler channels.

Issuing bodies include a county health department (Seminole County), a state health agency (Texas HHS Commission), a municipal fire department (City of Tampa), and a multistate cooperative purchasing organization (MMCAP, administered by Minnesota Department of Administration). Geographic activity spans Florida, Texas, Minnesota, and Oregon through cooperative arrangements. Recent opportunities include Seminole County's IFB 60459723LAS seeking 1,900 units of naloxone and 800 drug deactivation systems annually (due July 26, 2023); the City of Tampa's IFB 26P00145 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 (due March 13, 2026); Texas HHS's RFI HHS0017013 on direct-to-manufacturer prescription programs (due April 3, 2026); and MMCAP's RFP S1070000015802 for generic pharmaceuticals and OTC products distributed through authorized wholesalers, with proposals due March 26, 2026. The Tampa procurement is designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount available. Activity reflects ongoing state and local demand for pharmaceutical and medical supply sourcing through both direct procurement and cooperative purchasing vehicles.